1. Li CL, Cui JX, Wang CX, Li YH, Zhang L, Zhang L, Xiu X, Li YF, Na W. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage? J Pharm Sci. (in press) 2. Li CL, Cui JX, Wang CX, Zhang L, Xiu X, Li YH, Wei N, Li YF, Zhang L. Encapsulation of vinorelbine into cholesterol-PEG coated vesciles: drug loading and PK studies. J Pharm Pharmacol. 2011, 63: 376-384 3. Cui JX, Li CL, Wang CX, Li YH, Zhang L, Zhang L, Xiu X, Li YF, Wei N. Nigericin-mediated liposome loading of topotecan: is nigericin a potential drug release regulator? Int J Pharm. 2010, 399(1-2):31-36. 4. Li CL, Cui JX, Wang CX, Zhang L, Li YH, Zhang L, Xiu X, Li YF, Wei N. Development of pegylated liposomal vinorelbine formulation using "post-insertion" technology. Int J Pharm. 2010, 391(1-2):230-236. 5.ChunLei Li, JingXia Cui, CaiXia Wang, YanHui Li, Lan Zhang, Xian Xiu, YongFeng Li, Na Wei, Li Zhang and Ping Wang. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation. J Pharm Pharmacol (in press)